These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3106259)

  • 21. Cell-mediated immunity in patients with less than pemphigus vulgaris greater than before, during and after prolonged treatment with steroids.
    Shohat B; David M; Feuerman EJ
    Biomedicine; 1981 Jul; 35(3):101-3. PubMed ID: 6974011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and toxicity of retreatment with gold salts: a retrospective review of 25 cases.
    Sagransky DM; Greenwald RA
    J Rheumatol; 1980; 7(4):474-8. PubMed ID: 6775078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclophosphamide pulses with oral prednisolone in the treatment of pemphigus: a pilot study.
    Bhat R; Sharma VK; Ramam M; Kumar A
    Dermatol Online J; 2005 Dec; 11(3):4. PubMed ID: 16409900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Successful treatment of corticoid-resistant pemphigus with high-dose intravenous immunoglobulins].
    Sibaud V; Beylot-Barry M; Doutre MS; Beylot C
    Ann Dermatol Venereol; 2000 Apr; 127(4):408-10. PubMed ID: 10844264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of juvenile pemphigus vulgaris with intravenous immunoglobulin therapy.
    Asarch A; Razzaque Ahmed A
    Pediatr Dermatol; 2009; 26(2):197-202. PubMed ID: 19419473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cyclosporin A in the treatment of pemphigus foliaceus and pemphigus erythematosus].
    Balda BR; Rosenzweig D
    Hautarzt; 1986 Aug; 37(8):454-7. PubMed ID: 3531092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Gold therapy in pemphigus].
    Barriere H; Pasquiou C; Forest JL
    Ann Dermatol Venereol; 1977 Nov; 104(11):781-2. PubMed ID: 612262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gold therapy: dermatologic uses and toxicities.
    Penneys NS
    J Am Acad Dermatol; 1979 Oct; 1(4):315-20. PubMed ID: 159912
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of severe pemphigus with protein A immunoadsorption, rituximab and intravenous immunoglobulins.
    Shimanovich I; Nitschke M; Rose C; Grabbe J; Zillikens D
    Br J Dermatol; 2008 Feb; 158(2):382-8. PubMed ID: 18070210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Neumann type pemphigus vegetans with fatal outcome].
    Näher H
    Hautarzt; 1993 Feb; 44(2):99-102. PubMed ID: 8449702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Determination of gold deposition with a new analytical technic (PIXE)].
    Enderer K; Steigleder GK; Bischof W; Gonsior B
    Z Hautkr; 1984 Mar; 59(6):369-72. PubMed ID: 6326404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two courses of rituximab (anti-CD20 monoclonal antibody) for recalcitrant pemphigus vulgaris.
    Faurschou A; Gniadecki R
    Int J Dermatol; 2008 Mar; 47(3):292-4. PubMed ID: 18289336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dexamethasone-cyclophosphamide pulse therapy in bullous autoimmune dermatoses].
    Appelhans M; Bonsmann G; Orge C; Bröcker EB
    Hautarzt; 1993 Mar; 44(3):143-7. PubMed ID: 8463094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoablative high-dose cyclophosphamide without stem cell rescue in a patient with pemphigus vulgaris.
    Hayag MV; Cohen JA; Kerdel FA
    J Am Acad Dermatol; 2000 Dec; 43(6):1065-9. PubMed ID: 11100024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of severe pemphigus with rituximab: report of 12 cases and a review of the literature.
    Cianchini G; Corona R; Frezzolini A; Ruffelli M; Didona B; Puddu P
    Arch Dermatol; 2007 Aug; 143(8):1033-8. PubMed ID: 17709662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolonged remission after immunosuppressive therapy in six dogs with pemphigus foliaceus.
    Olivry T; Bergvall KE; Atlee BA
    Vet Dermatol; 2004 Aug; 15(4):245-52. PubMed ID: 15305932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Steroid sparing effect of intravenous immunoglobulin therapy in patients with pemphigus foliaceus.
    Sami N; Qureshi A; Ahmed AR
    Eur J Dermatol; 2002; 12(2):174-8. PubMed ID: 11872417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of current data on the use of intravenous immunoglobulins in management of pemphigus vulgaris.
    Engineer L; Bhol KC; Ahmed AR
    J Am Acad Dermatol; 2000 Dec; 43(6):1049-57. PubMed ID: 11100022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of thiopurine methyltransferase activity in the safety and efficacy of azathioprine in the treatment of pemphigus vulgaris.
    Firooz A; Ghandi N; Hallaji Z; Chams-Davatchi C; Valikhani M; Karbakhsh Davari M
    Arch Dermatol; 2008 Sep; 144(9):1143-7. PubMed ID: 18794458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Gold therapy in psoriasis arthropathica].
    Nolting S; Kastrup W
    Hautarzt; 1978 May; 29(5):266-9. PubMed ID: 149095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.